- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03896906
Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surgery
Comparison of Preoxygenation With a High-flow Nasal Cannula and a Simple Mask Before Intubation During Induction of General Anesthesia in Patients Undergoing Head and Neck Surgery
Objectives: To assess arterial oxygen partial pressure (PaO2) at defined time points during the preoxygenation and to compare between high flow heated humidified nasal oxygen versus standard preoxygenation with oxygen insufflation via face mask over at least 5 minutes Methods: This randomized, single-blinded, prospective study was conducted at Asan Medical Center in Seoul, Republic of Korea.
Populations: Patients undergoing head and neck surgery Expected outcomes: The course of PaO2 levels is superior to those of the face mask during the whole preoxygenation procedure and after the intubation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale & background information:
Pre-oxygenation before general anesthesia is usually achieved using oxygen delivered via a facemask before induction of anesthesia; this potentially extends the time available for securing the airway before hypoxemia to 6 min. The lungs are commonly ventilated with a bag/facemask technique after induction, and this can be repeated if attempts at intubating the trachea are prolonged. However, facemask ventilation has traditionally been avoided in the circumstance which has the risk of gastric insufflation of gas, leading to increased intragastric pressure and raised risk of pulmonary aspiration of stomach contents. In addition, if difficult ventilation is anticipated, facemask ventilation may not be possible at all, and 6 minutes with hypoxemia may be insufficient for intubation.
An ideal preoxygenation to extend apnea tolerance during anesthesia induction is essential to avoid live threatening airway incidents. The high-flow nasal cannula, the OptiFlow System (Thrive, Fisher & Paykel®, Aukland New Zealand), has the ability to deliver warmed and humidified oxygen through specially designed nasal cannula and enable oxygen to be comfortably delivered at rates of > 70 liter/min. Several study showed that nasal delivery of humidified oxygen to paralyzed and anesthetized patients at these rates maintains oxygenation and achieves acceptable carbon dioxide concentration. The investigators hypothesized that an extended apneic period without facemask ventilation could be particularly beneficial to patients undergoing general anaesthesia.
Study goals and objectives:
To assess arterial oxygen partial pressure (PaO2) at defined time points during the preoxygenation and to compare between high flow heated humidified nasal oxygen versus standard preoxygenation with oxygen insufflation via face mask over at least 5 minutes
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 05505
- Jun-Young Jo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with head and neck cancer undergoing resection surgery planned arterial cannulation and invasive arterial blood pressure monitoring and arterial blood gas analysis
- Patients over 19-year old
- Patients who voluntarily participated in the study
- Patents in American Society of Anesthesia physical status 1-3
Exclusion Criteria:
- Patients who don't approve to participation
- Unable to give informed consent because of a language barrier
- Patients with severe respiratory disease
- Patients with severe cardiovascular or cerebrovascular disease
- Patients with severe psychiatric disorders
- Anyone who is not appropriate according to researcher's decision
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group N
pre-oxygenation with High-flow nasal cannula
|
Apply high flow heated (34 °C) and humidified nasal oxygen with the OptiFlow System (Thrive, Fisher & Paykel®, Aukland New Zealand) using a flow of 30 liter/minute and an inspiratory oxygen fraction (FiO2) of 1.0.
Increase the oxygen flow to 60 liter/minute over the course of the first minute.
Ask the patients not to speak during anesthesia induction and keep the mouth closed.
|
|
Active Comparator: Group M
pre-oxygenation with simple mask
|
Perform standard preoxygenation by oxygen insufflation via a face mask using the standard anesthesia ventilators (semicircular system) with 100% oxygen flow of 12 liter/minute.
The patients breathe with tidal volume.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PaO2 (arterial oxygen partial pressure) at pre-defined time points.
Time Frame: through study completion, an average of 10 minutes
|
changes of PaO2
|
through study completion, an average of 10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
degree of blood oxygenation oxygenation
Time Frame: through study completion, an average of 10 minutes
|
result of arterial blood gas analysis
|
through study completion, an average of 10 minutes
|
|
various patients' characteristics about airway
Time Frame: through study completion, an average of 10 minutes
|
upper lip bite test classification (class 1~3)
|
through study completion, an average of 10 minutes
|
|
degree of difficulty for intubation
Time Frame: through study completion, an average of 10 minutes
|
the number of attempts at laryngoscopy and use of any rescue maneuvers, seniority of the anesthesiologist
|
through study completion, an average of 10 minutes
|
|
degree of tissue oxygenation
Time Frame: through study completion, an average of 10 minutes
|
O2 saturation
|
through study completion, an average of 10 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Seong-Soo Choi, Dr., Department of Anesthesiology and Pain Medicine, Asan Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-0275
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Neoplasm
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedHead and Neck Neoplasm | Malignant Head and Neck NeoplasmUnited States
-
University of WashingtonGuerbetWithdrawnMalignant Neoplasm in the Head and Neck | Metastatic Malignant Neoplasm in the Head and NeckUnited States
-
University of PecsCompletedHead and Neck Cancer | Malignant Neoplasm | Benign Neoplasm
-
Second Affiliated Hospital of Guangzhou Medical...Recruiting
-
Lucid Lane, IncM.D. Anderson Cancer CenterRecruitingMalignant Solid Neoplasm | Malignant Thoracic Neoplasm | Malignant Head and Neck Neoplasm | Malignant Abdominal NeoplasmUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
Center Eugene MarquisCompletedLocally Advanced Malignant Neoplasm | Malignant Neoplasm of Head and NeckFrance
-
Thomas Jefferson UniversityWithdrawnMalignant Head and Neck NeoplasmUnited States
-
Vanderbilt UniversityJohns Hopkins UniversityWithdrawnRadiotherapy | Head and Neck NeoplasmUnited States
-
Cancer Research AntwerpRecruitingHead and Neck NeoplasmBelgium
Clinical Trials on High-flow nasal cannula
-
Aga Khan University Hospital, PakistanUnknownApneic Oxygenation
-
University of MiamiAmerican Thoracic SocietyRecruiting
-
Hospital Clinic of BarcelonaUnknownPatient Population Submitted to ERCPSpain
-
Wenxian LiRecruitingDifficult Airway | Awake Tracheal IntubationChina
-
Kuopio University HospitalCentral Finland Hospital District; Mikkeli Central Hospital; Siun soteRecruiting
-
Montefiore Medical CenterCompletedMorbid Obesity | Noninvasive Ventilation | Deep SedationUnited States
-
Samsung Medical CenterFisher and Paykel HealthcareCompletedAcute Respiratory FailureKorea, Republic of
-
Children's Hospital Los AngelesCompletedHigh Flow Nasal CannulaUnited States
-
American University of Beirut Medical CenterCompletedHigh-flow Nasal Cannula | Intravenous SedationLebanon